Approval · Notice of Compliance 26751 · 2021
ZEPZELCA: Notice of Compliance 26751
Issued September 29, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
Issued with conditions (NOC/c): the company must confirm the benefit in further studies.
- Notice number
- 26751
- Date
- September 29, 2021
- Company
- Jazz Pharmaceuticals Ireland LimitedDublin, Dublin, Ireland
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- With conditions
- Yes (NOC/c)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZEPZELCA | 02520834 | Dormant |
Medicinal ingredients
- LURBINECTEDIN 4 MG per VIAL